Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India

被引:93
|
作者
Ganie, Mohammad Ashraf [1 ]
Vasudevan, Vishnu [1 ]
Wani, Imtiyaz Ahmad [1 ]
Baba, Mohammad Salem [1 ]
Arif, Tasleem [1 ]
Rashid, Aafia [1 ]
机构
[1] Sherikashmir Inst Med Sci, Dept Endocrinol & Metab, Srinagar 190011, Jammu & Kashmir, India
基金
美国国家卫生研究院;
关键词
Epidemiology; genetics; India; management; pathogenesis; pathophysiology; polycystic ovary syndrome; prevalence; SINGLE-NUCLEOTIDE POLYMORPHISM; CARDIOVASCULAR RISK-FACTORS; TYPE-2; DIABETES-MELLITUS; ANTI-MULLERIAN HORMONE; INSULIN-RESISTANCE; ETHINYL ESTRADIOL; DIAGNOSTIC-CRITERIA; METFORMIN TREATMENT; SYNDROME ETIOLOGY; OXIDATIVE STRESS;
D O I
10.4103/ijmr.IJMR_1937_17
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Polycystic ovary syndrome (PCOS) is a common endocrine disorder predominantly affecting women of reproductive age. Clinical manifestations are diverse including hyperandrogenism, anovulation, infertility and increased risk of metabolic diseases besides psychosocial dysfunction. This review provides information on the problem of PCOS in India, its pathophysiology, genetics and an overview of current management options to instigate further research in this field. Prevalence of PCOS in India ranges from 3.7 to 22.5 per cent depending on the population studied and the criteria used for diagnosis. Abnormalities in leptin-adiponectin (adipocyte biology), oxidative stress and autoimmunity are among the mechanisms studied regarding pathogenesis of PCOS. Many candidate gene studies have shown associations with PCOS in various studies. Studies have consistently demonstrated the relationship between the well-known manifestation of hyperandrogenism among Indian PCOS women and the metabolic morbidities including insulin resistance, glucose intolerance and cardiovascular risk. Management of individual components of PCOS can be achieved by medications or surgical methods, though further clarification regarding pathogenesis of PCOS is needed to sharpen our therapeutic armamentarium.
引用
收藏
页码:333 / 344
页数:12
相关论文
共 50 条
  • [1] Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome
    Goodarzi, Mark O.
    Azziz, Ricardo
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 20 (02) : 193 - 205
  • [2] Epidemiology, diagnosis, and management of polycystic ovary syndrome
    Sirmans, Susan M.
    Pate, Kristen A.
    [J]. CLINICAL EPIDEMIOLOGY, 2014, 6 : 1 - 13
  • [3] Genetics of polycystic ovary syndrome
    Legro, R.
    [J]. HUMAN REPRODUCTION, 2006, 21 : I31 - I31
  • [4] The genetics of polycystic ovary syndrome
    Amato, P
    Simpson, JL
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2004, 18 (05) : 707 - 718
  • [5] Genetics of polycystic ovary syndrome
    Sheikhha, Mohammad Hasan
    Kalantar, Seyed Mehdi
    Ghasemi, Nasrin
    [J]. IRANIAN JOURNAL OF REPRODUCTIVE MEDICINE, 2007, 5 (01) : 1 - 5
  • [6] Genetics of polycystic ovary syndrome
    Mykhalchenko, Kateryna
    Lizneva, Daria
    Trofimova, Tatiana
    Walker, Walidah
    Suturina, Larisa
    Diamond, Michael P.
    Azziz, Ricardo
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (07) : 723 - 733
  • [7] The genetics of polycystic ovary syndrome
    Balen, AH
    Wijeyaratne, CN
    [J]. UPDATES IN INFERTILITY TREATMENT 2004, 2004, : 395 - 417
  • [8] The genetics of the polycystic ovary syndrome
    Margrit Urbanek
    [J]. Nature Clinical Practice Endocrinology & Metabolism, 2007, 3 : 103 - 111
  • [9] Genetics of Polycystic Ovary Syndrome
    Prapas, N.
    Karkanaki, A.
    Prapas, I
    Kalogiannidis, I
    Katsikis, I
    Panidis, D.
    [J]. HIPPOKRATIA, 2009, 13 (04) : 216 - 223
  • [10] The genetics of the polycystic ovary syndrome
    Urbanek, Margrit
    [J]. NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM, 2007, 3 (02): : 103 - 111